November 17, 2026 | 11:00 AM ET
Virtual
The GLP-1 Access Gap: Where Patients Were Lost in 2026, and How to Keep Them Going Into 2027
Fewer than 1 in 3 approved obesity GLP-1 prescriptions are ever filled, and about 45% of Zepbound prescriptions are now self-pay, often outside the practice’s view. This 60-minute working session covers where approved patients are lost and what organizations need in place going into 2027.
Speaker : Dr. Steve Strongwater
Chief Medical Officer, PrescriberPoint (former President and CEO, Atrius Health)
Speaker : Raj Bhatnagar
Chief Executive Officer, Neolytix
Speaker : Andrew Borgschulte
Director of HCP Product Marketing, PrescriberPoint
Speaker : Brian Morefield
Director, Business Development, Neolytix



